This reciprocal regulation suggests a sophisticated regulatory circuit where DHCR24 potentially suppresses TP53 activity and sustains cholesterol biosynthesis, mechanisms that are both known to influence immune cell function and tumor surveillance. This evidence concerns the gene DHCR24 and neoplasm.